DXCM
DexCom, Inc. · Healthcare
EVP Strategy, Corporate Dev Matthew Vincent Dolan sold $274K of DexCom, Inc.
Sold$274,242
$137.81Price
1,990Shares
−4%Stake
What DXCM did after the filing
- The stock from Tue, Apr 16 close, $136.52
- −6.5%
- S&P 500, same days
- +4.5%
Measured over 30 trading days, to the May 29 close.
Traded Mon, Apr 15. Filed Tue, Apr 16, 12:16 PM ET, during the session. Returns use the Apr 16 close and the May 29 close. Not investment advice.